Skip to content

Clinical study of posterior circulation infarction with vertigo

Clinical study of posterior circulation infarction with vertigo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-10000760
Enrollment
Unknown
Registered
2010-01-18
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic infarction and vertigo

Interventions

Group A(no vertigo):cliniical observation
Group B(with vertigo):cliniical observation

Sponsors

The first affiliated hospital, Sun Yat-sen university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 years old and over; 2. Able and willing to provide signed informed consent; 3. Diagnosed as ischemic stroke; 4. Responsive lesions located in the posterior circulation area; 5. Within one month after acute stroke onset.

Exclusion criteria

Exclusion criteria: 1. with severe diseases in heart, liver, kidney, or severe anemia; 2. with peripheral vestibular vertigo such as BPPV and Meniere's Disease, or with vertigo caused by autonomic nerve dysfunction; 3. with other none-vascular vertigo caused by cerebellopontine angle inflammation or tumor, multiple sclerosis, cancer around the fourth ventricle; 4. taking aminoglycoside antibiotics, antispasmodic drugs (eg phenytoin), antidepressants, antihypertensive drugs, barbiturates, cocaine, furosemide, nitroglycerin, quinine, salicylates, sedatives / sleeping pills and other drugs that may cause vertigo/dizziness; Within 4 weeks prior to the last vertigo,/dizziness onset; 5. with severe infection in eyes, ears, mouth, nasopharynx or lung within two weeks prior to the onset of serious infection; 6. patients with consciousness, sensory aphasia, severe motor aphasia, mental retardation or mental symptoms.

Design outcomes

Primary

MeasureTime frame
hypertension;hypercholesterolemia;NIHSS scale;location of lesions;coronary heart disease;

Contacts

Public ContactWenli Sheng
qyeileen@163.com+86 13609723294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026